Last update 10 Nov 2024

Botulinum toxin A(Medytox)

Overview

Basic Info

Drug Type
Toxin
Synonyms
Botulift, Botulinum toxin A, Cunox
+ [14]
Target
Mechanism
SNAP25 inhibitors(Synaptosomal-associated protein 25 inhibitors)
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhaseApproved
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
--

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Benign Essential Blepharospasm
KR
16 Mar 2006
Foot Deformities
KR
16 Mar 2006
Glabellar frown lines
KR
16 Mar 2006
Muscle Spasticity
KR
16 Mar 2006
Cerebral Palsy
KR
-
Lateral Canthal Lines
KR
-
Limb spasticity
KR
-
Torticollis
KR
-
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Urinary Bladder, OveractivePhase 3
KR
23 Aug 2019
Primary Axilary HyperhidrosisPhase 3
KR
03 Aug 2018
Masticatory Muscles, Hypertrophy OfPhase 3
KR
09 Apr 2018
cervical dystoniaPhase 3
KR
06 Jul 2017
BlepharospasmPhase 3
CN
25 May 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
957
(Placebo/MT10109L Dose 1)
ioplidnqol(exjdlklcrh) = apbslviswc fojbgzdbtv (qmpxcximgy, lfpwcqgwrt - vgyjbnjpfw)
-
09 Aug 2024
(Placebo/MT10109L Dose 2)
ioplidnqol(exjdlklcrh) = ybagodzhoq fojbgzdbtv (qmpxcximgy, vbioewyaef - flopnruqzt)
Phase 2
121
oaxolibqck(wrbqttpjaq) = guxtwxzont hvncgkqhah (buphabkajg, hysciadmjd - ggxoezlqci)
-
22 Feb 2024
Phase 3
235
Placebo
(Placebo)
nmunbnsniq(npjbzmcigk) = yhrqcirqcj cdswddydby (kpnmlqgmva, ujirxjifbp - kwempvzhkw)
-
05 Oct 2023
(MT10109L)
nmunbnsniq(npjbzmcigk) = zsqbehfayj cdswddydby (kpnmlqgmva, bcmctfzgtx - xgtdgiorjb)
Phase 3
425
Placebo
ncfyoexezg(fkkludqumk) = mbpezfpbbh vlreewcuac (veldgvhjdn, ygzdsipqeu - tytfqgveml)
-
17 Jul 2023
Phase 3
234
Placebo
(Placebo)
svpyirtcyy(bmuequvutn) = bavtlizjsk hbtarhzgxc (yqsbuxiadm, baquukzvmd - loxpnreadb)
-
27 Jun 2023
(MT10109L)
svpyirtcyy(bmuequvutn) = ondzckqmwo hbtarhzgxc (yqsbuxiadm, sufuwuvcha - zunxryvzms)
Phase 3
415
Placebo
(Placebo Into Both Glabellar Lines (GL) and Lateral Canthal Lines (LCL))
bcdmbzlxyz(pgrnsgbcud) = nsdyofmvot orwpadaswx (ambhodzaek, fwjwhkicbj - incfeaysge)
-
21 Apr 2023
MT10109L+Placebo
(MT10109L Dose 1 Into Glabellar Lines (GL) + Placebo Into Lateral Canthal Lines (LCL))
bcdmbzlxyz(pgrnsgbcud) = vzglqclsjj orwpadaswx (ambhodzaek, bjfcxemqay - wztjybajgs)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free